GLP-1 receptor agonists act primarily by enhancing postprandial insulin secretion and suppressing glucagon release, leading to improved glycemic control (48, 49)
Weighted logistic regression models were applied to examine the association between OBS and the prevalence of gallstones, complemented by subgroup and sensitivity analyses
It also plays crucial roles in the immune response, DNA repair, mitochondrial function and the detoxification of drugs, chemicals, heavy metals, radiation, metabolic wastes, and other toxins and carcinogens
This makes the peptide widely accessible, even for individuals who cannot undergo hormone replacement therapy
Underlying medical risks: Certain health conditions, medications, or personal medical histories can make GLP-1 therapy unsafe